This translates to 4% adjusted EPS growth, excluding the unfavorable impact of foreign exchange. As such, we expect second quarter adjusted EPS of $0.79, which represents 4% growth over the prior year quarter.” Visit www.avient.com to learn more. 4 Forward-looking Statements In this press release, statements that are not reported financial results or other historical information are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.

主要特性 在三个通过ISO 13485认证的医疗生产线生 产全球统一的配方，提供全球一致性和供应 链保障 变更控制记录不限于CAS编号级别，降低变 更风险 不含动物源性物质和邻苯二甲酸盐 可将颜色与添加剂相结合，以增强产品性能 和防护性能 法规支持 经过预测试的原材料： - 美国药典（USP）23，第87和88章（VI类） 萃取和生物学评价 - ISO 10993，第4、5、10、11和18部分， 萃取和生物学评价 - 美国药典和欧洲药典中针对USP 、 ICH Q3D可萃取金属和EP3.1聚烯烃的测试的 其他监管支持信息 FDA器械主文件 食品接触符合FDA/EU*要求 针头的标称外径 （mm） 颜色说明 RAL 潘通色号 透明产品代码 不透明产品代码 0.4 中灰色 7035 423 C PP7M665125 PP7M665127 0.45 褐色 8017 7588 C PP8M665294 PP8M665296 0.5 橘黄色 2003 173 C PP2M665298 PP2M665300 0.55 中紫色 4005 7676 C PP4M665290 PP4M665292 0.6 深蓝色 5010 288 C PP5M665894 PP5M665896 0.7 黑色 9005 黑色 C PP9M664950 PP9M664952 0.8 深绿色 6001 7483 C PP6M665687 PP6M665689 0.9 黄色 1021 115 C PP1M665211 PP1M665213 1.1 乳白色 1015 7401 C PP0M665290 PP0M665292 1.2 粉色 3015 502 C PE3M665725 PP3M665727 适用医疗保健使用限制—见下文。 在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。

Novel TPE materials that can overmold onto various engineering plastics also were reported elsewhere (2-4). Krishna Venkataswamy, Jiren Gu and Walter Ripple, “A Novel Robust Polyamide Overmold Thermoplastic Elastomer, John Simons,” RAPRA 2005 4.

KEY CHARACTERISTICS • Meets critical need for thermal weldability and kink resistance • Minimizes extractables during processing • Provides excellent tensile strength • Complies with USP VI and ISO 10993-4, -5, -11 certifications • Suitable for gamma and autoclave sterilization methods • Bio-based grade option formulated with nearly 40% Gen 1 biomass content PRODUCT OVERVIEW 1.844.4AVIENT www.avient.com Copyright © 2023, Avient Corporation.

法规支持 经过预测试的原材料： - ISO 10993-1 - USP 第、章（VI类） - USP （指南），6.2.3 可萃取元素； USP - ICHQ3D/USP 2 可萃取金属 - 欧洲药典 3.1 聚烯烃（如适用） FDA发布的注册药品管理档案（III类）和/或医 疗器械管理档案 食品接触符合FDA/EU*要求 主要特性 在三个通过ISO 13485认证的医疗生产线生产 全球统一的配方，提供全球一致性和供应链保 障 变更控制记录的不限于CAS编号级别，降低变 更风险 不含动物源性物质和邻苯二甲酸盐 标准母粒在PE载体中提供，可根据要求在PP 中提供 可以采用针对应用选择的特定树脂提供预着色 配方 药物类型 颜色说明 潘通色号参考 埃万特产品代码 （PE基） 肾上腺素能激动剂组合 浅绿色 373 C PE6M176349 肾上腺素能激动剂 紫色 2583 C PE4M176057 抗感染药 棕褐色 467 C PE8M176130 非甾体类抗炎药 灰色 冷灰色 4 C PE7M176184 甾体类抗炎药 粉色 197 C PE3M176237 免疫调节剂类抗炎药 橄榄绿 5763 C 按要求提供 β-受体阻滞剂 黄色 黄色 C PE1M176160 β-受体阻滞剂组合 深蓝色 281 C PE5M176272 碳酸酐酶抑制剂 橘黄色 1585 C PE2M176089 细胞毒素 黑色 6 C PL9M176008 缩瞳剂 深绿色 348 C PE6M176267 散瞳剂和睫状肌麻痹剂 红色 1797 C PE3M176236 前列腺素类似物 绿松石 326 C PE5M176273 适用医疗保健使用限制—见下文。 在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。

WHAT WE DO: MATERIAL SCIENCE CUSTOM FORMULATION SUSTAINABILITY FOR A BETTER TOMORROW Revenue From Sustainable Solutions* 2016-2021 $310 205 140 80 75 45 40 20 $915M2021 Sales *Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”) **2020 is Pro Forma to include full year of the Clariant Color business Future Growth Revenue Assumptions From Sustainable Solutions: 8 - 12% 6 AVIENT ESG RATINGS Sustainalytics 2021 ESG Risk Ranking RANK (1st = lowest risk) PERCENTILE (1st – lowest risk) Chemicals INDUSTRY 75/449 17th Specialty Chemicals SUBINDUSTRY 21/124 17th ISS March 2022 ESG Scores SCORE (1 = Best, 10 = Worst) Environmental 2 Social 1 Governance 4 777 F I RS T Q UART E R 2022 RE S U LT S $123 $136 $0.89 $0.99 Q1 2022 PERFORMANCE 9 $1,162 $1,294 (+ 14% excluding FX) Adjusted EPS (+ 15% excluding FX) (+ 16% excluding FX) (in millions) (in millions) Sales Adjusted Operating Income Q1 2022 SEGMENT PERFORMANCE 10 CAI $609 $650 SEM Distribution $89 $95 + 7% (+ 10% excluding FX) $363 $433 $24 $24 + 19% Flat $217 $245 $34 $40 + 7% (+ 11% excluding FX) + 13% (+ 17% excluding FX) + 18% (+ 20% excluding FX) Q1 2021 $1,162 $123 Sustainable Solutions 19 8% 7 Healthcare 32 21% 6 Composites (excl. Outdoor High Performance) 8 18% 3 Growth in Asia / LATAM 6 3% 2 Other 100 19% 5 Sub-total $1,327 14% $146 Outdoor High Performance Impact (5) (3) Wage Inflation and Overtime (11) Other Supply Chain Costs (4) Synergies 5 Incentives, Other Employee Costs 8 FX (28) (5) Q1 2022 $1,294 11% $136 Q1 2022 SALES AND OPERATING INCOME Sales Growth Rate Operating Income$ millions EBITDA Q1 EBITDA BRIDGE 12 Price increases more than offset raw material and supply chain impacts Q1 2021 $ 161 Demand (23) $ millions CAI: Price / Mix 77 Inflation (54) SEM: Price / Mix 41 Inflation (26) Distribution: Price / Mix 84 Inflation (82) Net Price Benefit 40 Wage Inflation and Overtime (11) Other Supply Chain Costs (4) Synergies 5 Incentives, Other Employee Costs 8 FX (5) Q1 2022 $ 171 China Lockdowns / Russia Impact $ (7) Transportation (7) Outdoor High Performance (3) Q1 EPS BRIDGE 13 Q1 2021 - Adjusted EPS 0.89$ CAI 0.08 Specialty Engineered Materials 0.06 Distribution 0.00 Corporate Costs 0.02 F/X (0.04) Segment OI 0.12 Tax Rate (0.02) Q1 2022 - Adjusted EPS 0.99$ 2022 O U T LO O K REVENUE GROWTH DRIVERS Growth Drivers Long-Term Growth Rate 2022E Growth Rate Sustainable Solutions 8–12% 12% Healthcare 8–10% 10% Composites 10% 5% Asia / LATAM 5% 5% Other (GDP growth) 2–3% 2–3% Avient 6.5% 6% 15 Excluding Outdoor High Performance 20% (8% excl. OUR VALUATION VERSUS PEERS Avient Specialty Other 5.4 8.5 10.1 9.8 13.8 12.8 12.1 11.8 10.2 21.0 19.2 16.8 13.7 13.6 8.8 8.7 8.7 8.3 8.0 5.6 01 1) 01 6) 02 1) (T od ay ) PM PP AV VR C Historic Multiple APPENDIX Performance Additives 15% Pigments TiO2 Dyestuffs 3%Polyethylene Nylon 6% Polypropylene Other Raw Materials 30% Styrenic Block Copolymer ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials 48 • Significant raw material price inflation and tight inventory continued in Q1 2022 o The average cost of hydrocarbon based materials was up 30% o The average cost of non-hydrocarbon based materials was up 20% • Additionally, we continued to experience other supply chain challenges during Q1 related to raw material spot purchases, freight constraints and productivity loss as a result of these shortages Annual Purchases RAW MATERIAL AND SUPPLY CHAIN UPDATE Based on 2021 purchases, excludes Distribution business SEGMENT DATA U.S. & Canada 50% Latin America 2021 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS 23% 19% Building and END MARKET REVENUE (1) Total company sales and adjusted EBITDA of $4,819M and $581M, respectively, include intercompany sales eliminations and corporate costs $2,402M $409M $919M $164M $1,631M $94M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $581M$4,819M 15% 34% Building & 1% Telecommunications C O L O R , A D D I T I V E S & I N K S 2021 REVENUE | $2 .4 BILLION 32% 40% Latin America END MARKET REGION 51 S P E C I A LT Y E N G I N E E R E D M AT E R I A L S 27% Building & 2021 REVENUE | $919 MILLION END MARKET 55% REGION 52 DI S T RI BU T I O N 26% 23% Building and 80% 3% Latin America END MARKET REGION K EY SU PPL IER S 2021 REVENUE | $1 .6 BILLION 53 TOTA L C O M PA N Y R E G I O N A L S A L E S BY END MARKET 30% 26%Healthcare 14% Building & 2% Energy (16% of sales) 32% Building & (25% of sales) 54 19% Building & US & Canada (50% of sales) 38% 33% Building & LATAM (9% of sales) Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

Newlin said, “We finished 2013 very strong, building on our momentum throughout the year, and we are in an excellent position for another record year in 2014 with strong double-digit adjusted earnings per share growth. Attachment 4

Strong working capital performance to finish the year resulted in cash flow from operations of approximately Attachment 4

I am extremely pleased to finish the year with another record quarter and report the highest level of annual adjusted earnings we have ever achieved," said Attachment 4

They can also integrate aesthetic surface finishes to eliminate the need for wallpaper and/or paint.